STXS (Stereotaxis) Cyclically Adjusted PB Ratio: (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STXS Stereotaxis Inc STXS
63 GF Score
Price $1.62
GF Value $2.34
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Stereotaxis Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Stereotaxis  (AMEX:STXS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Stereotaxis Cyclically Adjusted PB Ratio Related Terms


Stereotaxis Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Stereotaxis's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stereotaxis Cyclically Adjusted PB Ratio Chart

Stereotaxis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Stereotaxis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STXS vs PDEX, KRMD, EMBC: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Stereotaxis's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stereotaxis Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Cyclically Adjusted PB Ratio falls into.


STXS
63GF Score
Stereotaxis Inc STXS
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stereotaxis Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Stereotaxis's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Stereotaxis's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.147/330.2130*330.2130
=0.147

Current CPI (Mar. 2026) = 330.2130.

Stereotaxis Quarterly Data

Book Value per Share CPI Adj_Book
201606 -0.992 241.018 -1.359
201609 -1.261 241.428 -1.725
201612 -0.974 241.432 -1.332
201703 -0.890 243.801 -1.205
201706 -0.887 244.955 -1.196
201709 -1.061 246.819 -1.419
201712 -1.165 246.524 -1.560
201803 0.039 249.554 0.052
201806 0.029 251.989 0.038
201809 0.030 252.439 0.039
201812 0.022 251.233 0.029
201903 -0.011 254.202 -0.014
201906 -0.022 256.143 -0.028
201909 0.342 256.759 0.440
201912 0.332 256.974 0.427
202003 0.312 258.115 0.399
202006 0.489 257.797 0.626
202009 0.475 260.280 0.603
202012 0.470 260.474 0.596
202103 0.469 264.877 0.585
202106 0.490 271.696 0.596
202109 0.464 274.310 0.559
202112 0.453 278.802 0.537
202203 0.433 287.504 0.497
202206 0.401 296.311 0.447
202209 0.371 296.808 0.413
202212 0.352 296.797 0.392
202303 0.316 301.836 0.346
202306 0.265 305.109 0.287
202309 0.231 307.789 0.248
202312 0.202 306.746 0.217
202403 0.177 312.332 0.187
202406 0.137 314.175 0.144
202409 0.128 315.301 0.134
202412 0.071 315.605 0.074
202503 0.033 319.799 0.034
202506 0.017 322.561 0.017
202509 0.069 324.800 0.070
202512 0.141 324.054 0.144
202603 0.147 330.213 0.147

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Stereotaxis (STXS) Overvalued in 2026?

Based on GuruFocus' analysis, Stereotaxis stock appears to be undervalued. The current stock price of $1.62 is trading 30.8% below its estimated GF Value™ of $2.34. GuruFocus considers Stereotaxis to be Possible Value Trap.

Key valuation signals for STXS:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $2.34 vs. price of $1.62 (30.8% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the STXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stereotaxis Business Description

Other Exchanges RJR1:Germany
Address 710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
63GF Score

Get the complete analysis for STXS

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.62
Price
$2.34
GF Value